Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) ROA %: 7.96% (As of Mar. 2026) — Near Median


SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
86 GF Score
Price ¥58.50
GF Value ¥66.69
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co ROA %?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 +10.17% 86 ROA % is 7.96% as of Mar. 2026, which is 6% below its 10-year median of 8.51. GuruFocus rates SHSE:688336 with a GF Score™ of 86/100 and a GF Value™ of ¥66.69 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks better than 98.17% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sunshine Guojian Pharmaceutical (Shanghai) Co's annualized Net Income for the quarter that ended in Mar. 2026 was ¥712 Mil. Sunshine Guojian Pharmaceutical (Shanghai) Co's average Total Assets over the quarter that ended in Mar. 2026 was ¥8,953 Mil. Therefore, Sunshine Guojian Pharmaceutical (Shanghai) Co's annualized ROA % for the quarter that ended in Mar. 2026 was 7.96%.

The historical rank and industry rank for Sunshine Guojian Pharmaceutical (Shanghai) Co's ROA % or its related term are showing as below:

SHSE:688336' s ROA % Range Over the Past 10 Years
Min: -5.26   Med: 8.51   Max: 38.86
Current: 38.36

During the past 13 years, Sunshine Guojian Pharmaceutical (Shanghai) Co's highest ROA % was 38.86%. The lowest was -5.26%. And the median was 8.51%.

SHSE:688336's ROA % is ranked better than
98.17% of 1418 companies
in the Biotechnology industry
Industry Median: -32.87 vs SHSE:688336: 38.36

Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=712.472/8952.8395
=(Net Income / Revenue)*(Revenue / Total Assets)
=(712.472 / 1724.936)*(1724.936 / 8952.8395)
=Net Margin %*Asset Turnover
=41.3 %*0.1927
=7.96 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Sunshine Guojian Pharmaceutical (Shanghai) Co ROA % Related Terms


Sunshine Guojian Pharmaceutical (Shanghai) Co ROA % Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co ROA % Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.99 5.66 12.50 38.86

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.86 5.80 11.25 112.58 7.96

SHSE:688336 vs VRTX, REGN, ALNY: ROA % Comparison

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunshine Guojian Pharmaceutical (Shanghai) Co ROA % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's ROA % distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's ROA % falls into.


SHSE:688336
86GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
ROA % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co ROA % Calculation

Sunshine Guojian Pharmaceutical (Shanghai) Co's annualized ROA % for the fiscal year that ended in Dec. 2025 is calculated as:

ROA %=Net Income (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=2899.305/( (5965.027+8957.374)/ 2 )
=2899.305/7461.2005
=38.86 %

Sunshine Guojian Pharmaceutical (Shanghai) Co's annualized ROA % for the quarter that ended in Mar. 2026 is calculated as:

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=712.472/( (8957.374+8948.305)/ 2 )
=712.472/8952.8395
=7.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of 7.96% mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a ROA % of 7.96% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. This is near median its historical median of 8.51. According to the industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #26 out of 1418 companies in the Biotechnology industry, placing it in the top 1.8%.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's ROA % too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current ROA % of 7.96% is near median its 10-year median of 8.51. Based on the distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #26 out of 1418 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #26 out of 1418 companies for ROA %. This places Sunshine Guojian Pharmaceutical (Shanghai) Co in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. Sunshine Guojian Pharmaceutical (Shanghai) Co's current ROA % is 7.96%, which is near median its own 10-year median of 8.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥66.69, compared to a current price of ¥58.50 — trading 12.3% below its estimated fair value. The current ROA % is 7.96%, which is near median its 10-year median of 8.51. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current ROA % is 7.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥58.50 is trading 12.3% below its estimated GF Value™ of ¥66.69. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Modestly Undervalued.

Key valuation signals for SHSE:688336:

  • ROA %: 7.96% (near median its 10-year median of 8.51)
  • GF Value™: ¥66.69 vs. price of ¥58.50 (12.3% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
86GF Score

Get the complete analysis for SHSE:688336

ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥58.50
Price
¥66.69
GF Value